(Q45116919)

9 December 2017

title

Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia (English)

1 reference

9 December 2017

0 references

1 reference

6

Hagop M Kantarjian

1 reference

9 December 2017

9

Marina Konopleva

1 reference

9 December 2017

7

Michael Andreeff

1 reference

9 December 2017

2

Jeffrey L Jorgensen

1 reference

9 December 2017

1

Sergej Konoplev

1 reference

9 December 2017

8

L Jeffrey Medeiros

1 reference

9 December 2017

Deborah A Thomas

3

1 reference

9 December 2017

E Lin

series ordinal

4

1 reference

9 December 2017

Jan Burger

series ordinal

5

1 reference

9 December 2017

language of work or name

English

0 references

publication date

31 March 2011

1 reference

9 December 2017

1 reference

9 December 2017

volume

117

1 reference

9 December 2017

issue

20

1 reference

9 December 2017

page(s)

4689-4695

1 reference

9 December 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

CXCR4 regulates growth of both primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

The bicyclam AMD3100 story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

CXCR4 is a prognostic marker in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

The biology and therapy of adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Is high expression of the chemokine receptor CXCR-4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26113

7 January 2021

Identifiers

DOI

10.1002/CNCR.26113

1 reference

9 December 2017

1 reference